Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:28 AM
Ignite Modification Date:
2025-12-25 @ 12:28 AM
NCT ID:
NCT07218367
Eligibility Criteria:
Inclusion Criteria:
* Ability to provide written informed consent
* Karnofsky Performance Scale (KPS) of 70 or higher
* Suspected, newly diagnosed or recurrent IDH wild type WHO IV glioblastoma presenting as an intra-axial
* Expansile contrast-enhancing mass without evidence of metastatic disease
Exclusion Criteria:
* Diagnostic uncertainty such as history of extracranial malignancy or autoimmune disease
* Medical conditions prohibiting anesthesia or surgery
* Tumors involving eloquent brain areas as defined by MRI signal
* primary motor cortex, primary sensory cortex, sensorimotor fibers, primary language areas, arcuate fasciculus
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07218367
Study Brief:
Protocol Section:
NCT07218367